Abstract
Larrea tridentata Coville, synonymous with L. divaricata Cay. and L. mexicana Moric (Tyler, 1993), L. glutinosa Englem, creosote bush, greaseweed, hediondilla (Anonymous, 1993); L. nitida, L. ameghinoi, L. cuneifolia (Leonforte, 1986)
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agarwal R, Wang ZY, Bik DP, Mukhtar H. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450 mediated monooxygenase activity in rat epidermal and hepatic microsomes. Drug Metab Dispos 1991; 19: 620–4.
Alderman S, Kailas S, Goldfarb S, Singaram C, Malone DG. Cholestatic hepatitis after ingestion of chaparral leaf: confirmation by endoscopie retrograde cholangiopancreatography and liver biopsy. J Clin Gastroenterol 1994; 19: 242–7.
Anonymous: Chaparral-induced toxic hepatitis—California and Texas, 1992. Morbid Mortal Wkly Rep 1992; 41: 812–4.
Anonymous: The Lawrence review of natural products. St. Louis, MO: Facts and Comparisons, 1993.
Batchelor WB, Heathcote J, Wanless IR. Chaparral-induced hepatic injury. Am J Gastroenterol 1995; 90: 831–3.
Blumenthal M. The complete German Commission E monographs. Austin, TX: American Botanical Council, 1998.
Burk D, Woods M. Hydrogen peroxide, catalase, glutathione peroxidase, quinones, nordihydroguaiaretic acid, and phosphopyridine nucleotides in relation to x-ray action on cancer cells. Radiat Res 1963; 3 (Suppl): 212–46.
Capdevila J, Gil L, Orellana M, Marnett LJ, Mason JI, Yadagiri P, Falck JR. Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism. Arch Biochem Biophys 1988; 261: 257–63.
Evan AP, Gardner KD. Nephron obstruction in nordihydroguaiaretic acid-induced renal cystic disease. Kidney Int 1979; 15: 7–19.
Goodman T, Grice HC, Becking GC, Salem FA. A cystic nephropathy induced by nordihydroguaiaretic acid in the rat. Light and electron microscopic investigations. Lab Invest 1979; 23: 93–107.
Gordon, D, Rosenthal G, Hart J, Sirota R, Baker A. Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications. JAMA 1995; 273: 489–90.
Grice HC, Becking G, Goodman T. Toxic properties of nordihydroguaiaretic acid. Food Cosmet Toxicol 1968; 6: 155–61.
Kemal C, Louis-Flamberg P, Krupinski-Olsen R, Shorter AL. Reductive inactivation of soybean lipoxygenase 1 by catechols: a possible mechanism for regulation of lipoxygenase activity. Biochemistry 1987; 26: 7064–72.
Leonforte J. Contact dermatitis from Larrea (creosote bush). J Am Acad Dermatol 1986; 14: 202–7.
Luo J, Chuang T, Cheung J, Quan J, Tsai J, Sullivan C, et al. Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata). Eur J Pharmacol 1998; 346: 77–9.
Obermeyer WR, Musser SM, Betz JM, Casey RE, Pohland AE, Page SW. Chemical studies of phytoestrogens and related compounds in dietary supplements: flax and chaparral. Proc Soc Exp Biol Med 1995; 208: 6–12.
Pavani M, Fones E, Oksenberg D, Garcia M, Hernandez C, Cordano G, et al. Inhibition of tumoral cell respiration and growth by nordihydroguaiaretic acid. Biochem Pharmacol 1994; 48: 1935–42.
Robison T, Sevanian A, Forman H. Inhibition of arachidonic acid release by nordihydroguaiaretic acid and its antioxidant action in rat alveolar macrophages and Chinese hamster lung fibroblasts. Toxicol Appl Pharmacol 1990; 105: 113–22.
Salari H, Braquet P, Borgeat P. Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostagland Leukatr Med 1984; 13: 53–60.
Sheikh NM, Philen RM, Love LA. Chaparral associated hepatotoxicity. Arch Intern Med 1997; 157: 913–9.
Smart CR, Hogle HH, Robins RK, Broom AD, Bartholomew D. An interesting observation on nordihydroguaiaretic acid (NSC-4291; NDGA) and a patient with malignant melanoma—a preliminary report. Cancer Chem Rep 1969; 53: 147–51.
Smith AY, Feddersen RM, Gardner KD, Davis CJ. Cystic renal cell carcinoma and acquired renal cystic disease associated with consumption of chaparral tea: a case report. J Urol 1994; 152: 2089–91.
Stone B. Chaparral consumption warning. HHS News P92–38. Rockville, MD: Food and Drug Administration, December 10, 1992.
Tyler V. The honest herbal, 3rd edit., Binghamton, NY: Pharmaceutical Products Press, 1993.
Waller C, Gisvold O. A phytochemical investigation of Larrea divaricata Cay. J Am Pharm Assoc 1945; 34: 78–81.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Melgarejo, K., Cupp, M.J. (2000). Chaparral. In: Cupp, M.J. (eds) Toxicology and Clinical Pharmacology of Herbal Products. Forensic Science and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-020-9_17
Download citation
DOI: https://doi.org/10.1007/978-1-59259-020-9_17
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-190-5
Online ISBN: 978-1-59259-020-9
eBook Packages: Springer Book Archive